Home Cart Sign in  
Chemical Structure| 36396-99-3 Chemical Structure| 36396-99-3

Structure of N6-Cyclohexyladenosine
CAS No.: 36396-99-3

Chemical Structure| 36396-99-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

N6-Cyclohexyladenosine is a selective A1 receptor agonist (EC50 = 8.2 nM).

Synonyms: CHA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of N6-Cyclohexyladenosine

CAS No. :36396-99-3
Formula : C16H23N5O4
M.W : 349.38
SMILES Code : OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2NC1CCCCC1
Synonyms :
CHA
MDL No. :MFCD00036808
InChI Key :SZBULDQSDUXAPJ-XNIJJKJLSA-N
Pubchem ID :9841284

Safety of N6-Cyclohexyladenosine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Related Pathways of N6-Cyclohexyladenosine

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rabbit cortical collecting duct cell line (RCCT-28A) 10^-7 M or 10^-6 M 2-3 minutes CHA activates the Cl- channel by stimulating A1 adenosine receptors, increasing the open probability (P_o). J Clin Invest. 1992 Mar;89(3):834-41
Rat cardiomyocytes 10^-6 M 30 min To study the effect of CHA (an adenosine A1 receptor agonist) on 5'-nucleotidase activity, results showed CHA significantly decreased ectosolic and cytosolic 5'-nucleotidase activity J Clin Invest. 1994 Dec;94(6):2451-6
Rat cardiomyocytes 10^-9 to 10^-4 M 15 min To study the effect of exogenous adenosine on 5'-nucleotidase activity, results showed adenosine significantly decreased ectosolic and cytosolic 5'-nucleotidase activity J Clin Invest. 1994 Dec;94(6):2451-6
rat outer medullary descending vasa recta (OMDVR) 10^-6 M 5 minutes To test the direct effect of CHA on untreated vessels, results showed that CHA (10^-6 M) caused vasoconstriction. J Clin Invest. 1996 Jul 1;98(1):18-23
rat outer medullary descending vasa recta (OMDVR) 10^-6 M 5 minutes To test the effect of CHA on ANG II-induced vasoconstriction, results showed that CHA (10^-6 M) had no significant effect on ANG II-induced vasoconstriction. J Clin Invest. 1996 Jul 1;98(1):18-23
Rabbit cortical collecting tubule (RCCT) cells 100 μM 30 minutes To investigate the effect of CHA on PGE2 production, results showed CHA did not affect PGE2 production. J Clin Invest. 1987 Mar;79(3):710-4
Rabbit cortical collecting tubule (RCCT) cells 50 nM 30 minutes To investigate the inhibitory effect of CHA on AVP- and isoproterenol-stimulated cAMP accumulation, results showed CHA inhibited cAMP accumulation via A1 receptor. J Clin Invest. 1987 Mar;79(3):710-4
Rabbit juxtaglomerular apparatus cells 10^-7 M 40 minutes To test the inhibitory effect of CHA on renin secretion, results showed that CHA significantly inhibited renin secretion, an effect completely blocked by CPX. J Clin Invest. 1990 May;85(5):1622-8

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Free-behaving rats Subarachnoid space infusion 2 pmol/min 6-hour continuous infusion CHA initially significantly suppressed slow-wave sleep (SWS) and paradoxical sleep (PS), followed by an increase in SWS in the later phase. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5980-4

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.86mL

0.57mL

0.29mL

14.31mL

2.86mL

1.43mL

28.62mL

5.72mL

2.86mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories